Data from a trial on hypertension show that a single-tablet, dual-mechanism therapy initiated in high-risk patients with hypertension significantly reduces the risk for morbidity and mortality by 20%. Medscape Medical News
In addition to the reduction in major bleeding, there were trends toward a reduction in ischemic events, although these did not reach statistical significance. A second study also showed that radial-access PCI in STEMI patients does not compromise reperfusion times. Heartwire
Three common ingredients in multivitamins, vitamins B6 and B12 and folic acid, had no significant effect on the risk for cancer in women, who were observed for an average of 7.3 years. Medscape Medical News
Think hypertension is just a "nuisance" condition? This month details the various manifestations of its enormous impact on the overall health status of developed societies. Medscape Cardiology
